Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists.
Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer JH, Osterwalder J, Frauchiger B, Aschwanden M, Matter CM, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky D.
Nagler M, et al.
J Thromb Haemost. 2017 Nov;15(11):2165-2175. doi: 10.1111/jth.13810. Epub 2017 Sep 25.
J Thromb Haemost. 2017.
PMID: 28834238
Free article.